whose general practitioner prescribed SPC amlodipine/valsartan (5 mg/80 mg, 5 mg/160 mg, or 10 mg/160 mg) as second-line therapy. Patients who did not tolerate prior line treatment could be ...

At baseline, 11.9% of patients were prescribed amlodipine/valsartan 5 mg/80 mg, 66.8% received 5 mg/160 mg, and 22.1% were treated with 10 mg/160 mg. At follow-up, these proportions were 9.0% ...